Radiochemicals for research and clinical use
BV Cyclotron VU is a global health science company that produces radiopharmaceuticals and radiochemicals for medical diagnostics and research. Located at the campus of VU University Medical Center in Amsterdam, Cyclotron VU produces GMP- compliant medical isotopes in state-of-the-art manufacturing facilities.
Our products are used daily by pharmaceutical and biotechnology companies, medical device manufacturers, hospitals, clinics, and research laboratories.
More information on Zirconium-89 for radiolabeling, Sodium Iodide 124I for injection, 18F-Fludeoxyglucose, 18F-Fluoromethylcholine 18F-Florbetaben, KryptoScanTM:81Rb/81mKrGenerator and Type A Transport Container: Lead and Tungsten.
Do you need precise details about when and where to order your product? See our production schedule here.
Also check out our free online decay calculator.
BV Cyclotron VU is a global health science company that produces radiopharmaceuticals and radiochemicals for medical diagnostics and research. Located at the campus of VU University Medical Center in Amsterdam, Cyclotron VU produces GMP- compliant medical isotopes in state-of-the-art manufacturing facilities.
Our products are used daily by pharmaceutical and biotechnology companies, medical device manufacturers, hospitals, clinics, and research laboratories.
More information on Zirconium-89 for radiolabeling, Sodium Iodide 124I for injection, 18F-Fludeoxyglucose, 18F-Fluoromethylcholine 18F-Florbetaben, KryptoScanTM:81Rb/81mKrGenerator and Type A Transport Container: Lead and Tungsten.
Do you need precise details about when and where to order your product? See our production schedule here.
Also check out our free online decay calculator.
Whole body positron emission tomography quantifies expression of PD-1 and PD-L1 in patients with non-small-cell lung cancer
26/11/2018: The latest issue of Nature Communications brings the results of a first-in-human biomarker exploratory study showing that tumor PD-L1 and PD-1 expression can be quantified non-invasively using PET-CT in patients with advanced non-small-cell lung cancer (NSCLC).
PET improves diagnosis and treatment of Alzheimer's Disease
31/10/2018: New results of the Dutch ABIDE project associates PET scans to essential changes in diagnosis and treatment of amyloid plaques in the brain
Clinical collaboration announced between Telix Pharmaceuticals and Radboud University Medical Center
10/4/2018: This highly interesting international collaboration lays the foundation for the completion of product development of 89Zr-Girentuximab